Antistaphylococcal activity of the fluoroquinolones CI-960, PD 131628, sparfloxacin, ofloxacin and ciprofloxacin
- 1 March 1991
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 10 (3), 168-171
- https://doi.org/10.1007/bf01964451
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- In vitro antibacterial activities of PD 131628, a new 1,8-naphthyridine anti-infective agentAntimicrobial Agents and Chemotherapy, 1991
- Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospitalAntimicrobial Agents and Chemotherapy, 1990
- Increasing resistance of Staphylococcus aureus to ciprofloxacinAntimicrobial Agents and Chemotherapy, 1990
- Antistaphylococcal activities of sparfloxacin (CI-978; AT-4140), ofloxacin, and ciprofloxacinAntimicrobial Agents and Chemotherapy, 1990
- In vitro activity of AT-4140 against quinolone- and methicillin-resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1990
- The prevalence of staphylococcal resistance to penicillinase-resistant penicillinsDiagnostic Microbiology and Infectious Disease, 1989
- Comparative in vitro activity of PD 127,391, a new fluorinated 4-quinolone derivativeAntimicrobial Agents and Chemotherapy, 1988
- In vitro activity of ciprofloxacin against gram-positive cocci.1987
- Method of reliable determination of minimal lethal antibiotic concentrationsAntimicrobial Agents and Chemotherapy, 1980